Summary of Study ST004350

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002759. The data can be accessed directly via it's Project DOI: 10.21228/M81G1D This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST004350
Study TitleThe metabolic effects of succinylation and desuccinylation of HADHB at lysine 292
Study SummaryTo elucidate the metabolic effects of succinylation and desuccinylation at lysine 292 (K292) of HADHB, we generated stable H9C2 rat cardiomyocyte cell lines expressing HADHB mutants. Specifically, lysine 292 was substituted with arginine (K292R) to mimic the desuccinylated state and with glutamic acid (K292E) to mimic the negatively charged succinylated modification. Non-targeted metabolomic profiling was performed on three groups—wild-type (WT), desuccinylation-mimic (K292R), and succinylation-mimic (K292E)—with six biological replicates per group. The metabolomic analysis revealed that succinylation at K292 of HADHB in cardiomyocytes leads to distinct metabolic alterations, particularly affecting the fatty acid β-oxidation pathway.
Institute
Nanchang University Second Affiliated Hospital
Last NameZeng
First NameZhimin
Addressnanchang, nanchang, jiangxi, 330006, China
Email2zm@163.com
Phone15979727903
Submit Date2025-11-07
Num Groups3
Total Subjects6
Raw Data AvailableYes
Raw Data File Type(s)mzML
Analysis Type DetailLC-MS
Release Date2025-12-05
Release Version1
Zhimin Zeng Zhimin Zeng
https://dx.doi.org/10.21228/M81G1D
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR002759
Project DOI:doi: 10.21228/M81G1D
Project Title:Untargeted metabolomic analysis of the metabolic effects of HADHB lysine 292 succinylation and desuccinylation
Project Summary:HADHB succinylation status variations may influence metabolic states. We generated stable H9C2 rat cardiomyocyte cell lines expressing HADHB mutants. Untargeted metabolomics revealed that the succinylation and desuccinylation states at lysine 292 of HADHB may affect the Beta Oxidation of Very Long Chain Fatty Acids.
Institute:Nanchang University Second Affiliated Hospital
Last Name:Zeng
First Name:Zhimin
Address:nanchang, nanchang, jiangxi, 330006, China
Email:2zm@163.com
Phone:15979727903

Subject:

Subject ID:SU004509
Subject Type:Mammal
Subject Species:Rattus norvegicus
Taxonomy ID:10116
Genotype Strain:HADHB-K292R、HADHB-K292E

Factors:

Subject type: Mammal; Subject species: Rattus norvegicus (Factor headings shown in green)

mb_sample_id local_sample_id Sample source Genotype
SA517166E6H9C2 cells HADHB-K292E
SA517167E5H9C2 cells HADHB-K292E
SA517168E4H9C2 cells HADHB-K292E
SA517169E3H9C2 cells HADHB-K292E
SA517170E2H9C2 cells HADHB-K292E
SA517171E1H9C2 cells HADHB-K292E
SA517172R5H9C2 cells HADHB-K292R
SA517173R6H9C2 cells HADHB-K292R
SA517174R4H9C2 cells HADHB-K292R
SA517175R3H9C2 cells HADHB-K292R
SA517176R2H9C2 cells HADHB-K292R
SA517177R1H9C2 cells HADHB-K292R
SA517178C2H9C2 cells Wild-type
SA517179C6H9C2 cells Wild-type
SA517180C5H9C2 cells Wild-type
SA517181C4H9C2 cells Wild-type
SA517182C3H9C2 cells Wild-type
SA517183C1H9C2 cells Wild-type
Showing results 1 to 18 of 18

Collection:

Collection ID:CO004502
Collection Summary:H9C2 cells were purchased from Pronova (Punosai/Pronova-style naming), and a lentiviral system designed by Hanheng was used to introduce a lysine-to-arginine mutation at position 292 in HADHB (K292R) to generate a non-succinylated mutant, and a lysine-to-glutamate mutation at the same site (K292E) to mimic succinylation. Stable cell lines were established for HADHB-K292R (non-succinylated mutant) and HADHB-K292E (succiny-lation-mimetic). Seed six replicates per group from three growth conditions into 10 cm culture dishes. When the cells reach confluence, wash 2–3 times with pre-chilled PBS, add 1 mL of chromatography-grade methanol to each dish, detach the cells with a scraper, and transfer them to a 2 mL cryovial. Snap-freeze in liquid nitrogen for 15 minutes and then store at −80°C. Non-targeted metabolomics sequencing was performed on the three groups.
Sample Type:Rat H9C2 cell line

Treatment:

Treatment ID:TR004518
Treatment Summary:No treatment.

Sample Preparation:

Sampleprep ID:SP004515
Sampleprep Summary:A 500 μL solution (Methanol: Water = 4:1, V/V) containing internal standard was added into the sample and vortexed for 3 min. The sample was placed in liquid nitrogen for 5 min and on the dry ice for 5 min, and then thawed on ice and vortexed for 2 min. This freeze-thaw circle was repeated three times in total. The sample was centrifuged at 12000 rpm for 10 min (4 °C). All of the supernatant was transferred and concentrated. A 100 μL solution (Methanol: Water = 7:3, V/V) was used to reconstitute the sample. Then the sample was vortexd for 3 minutes, and sonicate for 10 minutes in an ice bath. The sample was then centrifuged at 12000 rpm for 3 min (4 °C). A 80 μL aliquots of supernatant were transferred for LC-MS analysis.

Chromatography:

Chromatography ID:CH005511
Chromatography Summary:All samples were for two LC/MS methods. One aliquot was analyzed using positive ion conditions and was eluted from T3 column (Waters ACQUITY Premier HSS T3 Column 1.8 µm, 2.1 mm * 100 mm) using 0.1 % formic acid in water as solvent A and 0.1 % formic acid in acetonitrile as solvent B in the following gradient: 5 to 20 % in 2 min, increased to 60 % in the following 3 mins, increased to 99 % in 1 min and held for 1.5 min, then come back to 5 % mobile phase B witnin 0.1 min, held for 2.4 min. The analytical conditions were as follows, column temperature, 40 °C; flow rate, 0.4 mL/min; injection volume, 4 μL; Another aliquot was using negative ion conditions and was the same as the elution gradient of positive mode.
Chromatography Comments:Reversed-phase separation was performed on a Waters ACQUITY UPLC HSS T3 column (1.8 µm, 2.1 × 100 mm). The mobile phases consisted of (A) water with 0.1% formic acid and (B) acetonitrile. The flow rate was 0.3 mL/min. The gradient started at 2% B, increased linearly to 98% B over 15 min, held for 2 min, and then returned to initial conditions for re-equilibration. The column temperature was maintained at 40 °C, and the injection volume was 2 µL.
Instrument Name:Thermo Vanquish
Column Name:Waters ACQUITY UPLC HSS T3 (100 x 2.1mm,1.8um)
Column Temperature:40
Flow Gradient:0–2 min: 5%–20% B; 2–5 min: 20%–60% B; 5–6 min: 60%–99% B; 6–7.5 min: 99% B; 7.5–7.6 min: 99%–5% B; 7.6–10 min: 5% B (re-equilibration)
Flow Rate:0.4 mL/min
Solvent A:100% water; 0.1% acetic acid
Solvent B:100% acetonitrile; 0.1% acetic acid
Chromatography Type:Reversed phase

Analysis:

Analysis ID:AN007261
Analysis Type:MS
Chromatography ID:CH005511
Num Factors:3
Num Metabolites:1154
Units:Peak area
  
Analysis ID:AN007262
Analysis Type:MS
Chromatography ID:CH005511
Num Factors:3
Num Metabolites:779
Units:Peak Area
  logo